AMBU LAUNCHES NEW VIDEO LARYNGOSCOPY SOLUTION
With the launch of the Ambu® SureSight™ Connect solution, Ambu offers clinicians the only airway visualisation and pulmonology offering that features a one-lung ventilation solution and includes all the devices recommended for intubation and airway assessment.

Today, Ambu announces the launch of its new video laryngoscopy solution, Ambu® SureSight™ Connect, in full integration with Ambu’s advanced digital software systems, Ambu® aView™ 2 Advance and Ambu® aBox™ 2.
This new solution is designed to facilitate efficient intubation in both routine and difficult airway procedures in the operating room (OR) and intensive care unit (ICU). Endotracheal intubation is one of the most common airway management procedures, with over 15 million intubations performed annually in the USA alone.
The Ambu® SureSight™ Connect expands Ambu’s comprehensive airway visualization and pulmonology offering, making it the only offering that features a one-lung ventilation solution and includes all the devices recommended for intubation and airway assessment.1
"From the introduction of the first self-inflating resuscitation breathing bags in 1956, to the upcoming integration of state-of-the-art video laryngoscopy into a versatile airway visualization and pulmonology offering, Ambu is the anesthesiologist’s partner in providing the best care. I have worked with Ambu for more than 15 years and have found it to hold the highest standards in the development of airway tools and in teaching the clinician to appropriately apply them. Ambu seeks the input of clinicians, such as myself, in the development of devices that serve our patients and constantly strives for improvement."
DR. WILLIAM H. ROSENBLATT2
Professor at Yale University School of Medicine, USA
In addition to the new video laryngoscope, Ambu’s airway visualization and pulmonology offering includes the company’s range of single-use bronchoscopes, rhinolaryngoscopes as well as single- and double-lumen tubes with an integrated camera for one-lung ventilation procedures3 – all in integration with Ambu’s digital software systems. Ambu’s integrated airway visualization and pulmonology offering allows clinicians to switch between solutions as needed. This reduces task complexity and simplifies workflow efficiency in a cluttered workspace, giving clinicians more time to focus on patients, while maintaining high standards of patient safety.
Furthermore, the advanced data management capabilities of Ambu’s digital software systems enable clinicians to streamline the sharing of patient imaging data with hospitals’ IT systems.
Starting January 2025, Ambu will initiate the launch of the Ambu® SureSight™ Connect solution in the USA, followed by launches in additional markets throughout 2025. Initially, Ambu will engage in a so-called controlled market release phase, collaborating with healthcare professionals at key hospitals to evaluate the solution’s performance in clinical settings before engaging in a full commercial launch later in the financial year.
"With our new video laryngoscopy solution, we are significantly extending our airway visualization and pulmonology offering to our customers. This important advancement allows us to meet their needs with the most comprehensive portfolio in the industry, ensuring they can work more efficiently to deliver the highest standards of patient care. Furthermore, it solidifies Ambu’s strong leadership position in airway management and pulmonology, showcasing our continued commitment to customer-centric innovation."
BRITT MEELBY JENSEN
Chief Executive Officer, Ambu
------------------------------------------------
1 Recommended by the UK Difficult Airway Society; American Society for Anesthesiologists; Australian and New Zealand College of Anaesthetists & Faculty of Pain Medicine.
2 Dr. Rosenblatt has not been compensated for his quote in this press release.
3 Ambu’s single-lumen tubes, Ambu® VivaSight™ 2 SLT, are not commercially available in the USA.
Keywords
Contacts
Anders HjortHead of Investor Relations
Tel:+45 2892 8881anhj@ambu.comTine Bjørn SchmidtHead of Corporate Communications
Tel:+45 2264 0697tisc@ambu.comDocuments
About Ambu
Since 1937, Ambu’s DNA has been to rethink solutions together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions. Headquartered near Copenhagen in Denmark, Ambu employs around 5,000 people in North America, Europe, Latin America and Asia Pacific.
For more information, please visit Ambu.com.
Subscribe to releases from Ambu A/S
Subscribe to all the latest releases from Ambu A/S by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Ambu A/S
AMBU LAUNCHES FIRST-OF-ITS-KIND ENDOSCOPE RECYCLING PROGRAM TO ENHANCE WASTE REDUCTION IN HOSPITALS2.6.2025 10:27:09 CEST | Press release
Today, Ambu announces the launch of its new Ambu® Recircle program, teaming up with hospitals in both the US and the UK as the first key participants.
AMBU® SURESIGHT™ CONNECT VIDEO LARYNGOSCOPE EXPANDS WITH PAEDIATRIC BLADE OPTIONS12.5.2025 16:44:13 CEST | Press release
Ambu has expanded its newly launched Ambu® SureSight™ Connect video laryngoscopy solution with the introduction of five new blades designed specifically for paediatric patients.
AMBU APPOINTS NEW CHIEF MARKETING OFFICER1.5.2025 09:30:00 CEST | Press release
Jesper Johnsen Steen has been appointed as Ambu’s new Chief Marketing Officer, effective 1 May 2025.
AMBU EXPANDS CE MARK FOR EXISTING UROLOGY SOLUTION, ENABLES NEW TYPE OF PROCEDURE19.2.2025 10:41:31 CET | Press release
With the CE mark expansion for Ambu® aScope™ 5 Cysto HD, urologists will now be able to use the medical technology as a single-use flexible cysto-nephroscopy solution, reflecting Ambu’s commitment to addressing a growing range of urology needs for patients and healthcare professionals.
AMBU LAUNCHES HD CYSTOSCOPY SOLUTION IN THE U.S.17.10.2024 16:46:40 CEST | Press release
Following the FDA clearance for the Ambu® aScope™ 5 Cysto HD solution, Ambu introduces its HD cystoscope to urologists in the USA, expanding the urology offering and meeting advanced needs for cystoscopy procedures requiring superior image quality.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom